ArticleJournal of cancer research and clinical oncology2023

Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.

Doran Ksienski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.